Through a pioneering initiative called Chronos-PD, Grifols is partnering with the Michael J. Fox Foundation for Parkinson’s Research (MJFF) to identify early biological signals of Parkinson’s ...

Kepler Capital analyst Arnaud Girod maintained a Hold rating on Grifols SA (NASDAQ:GRFS) on Wednesday, setting a price target... Kepler Capital analyst Arnaud Girod maintained a Hold rating on ...

This page features the latest news about the Grifols Pref stock. Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton ...

Private equity firm Brookfield has said it is withdrawing from negotiations to take over Grifols, sparking a slump in the Spanish pharma group's share price. The Canadian investment group said it ...

After hours: March 21 at 4:14:03 PM EDT Loading Chart for GRFS ...